You Should Know These Things About BioSig Technologies Inc. (BSGM)


At the last check on Thursday, BioSig Technologies Inc.’s (NASDAQ:BSGM) stock was up $0.05, moving up 3.77 percent to $1.51. The average number of shares traded per day over the past five days has been 333,034 shares. 2 times new highs have been achieved over the past 5 days, with a $0.0401 gain in that time frame. In the last twenty days, the average volume was 263,409, while in the previous 50 days, it was 299,571.

Since last month, BSGM stock rose 23.17%. Shares of the company fell to $1.1400 on 04/27/23, the lowest level in the past month. A 52-week high of $1.58 was reached on 05/25/23 after having rallying from a 52-week low of $0.25. Since the beginning of this year, BSGM’s stock price has risen by 260.71% or $1.1101, and marked a new high 18 times. However, the stock has declined by -4.11% since its 52-week high.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


BSGM stock investors should be aware that BioSig Technologies Inc. (BSGM) stock had its last reported insider trading activity 255 days ago on Sep 12. Sieckhaus John, the Chief Operating Officer of the company, purchased of 5,000 shares for $0.91 on Sep 12. It resulted in a $4,550 investment by the insider. LONDONER KENNETH L added 29,700 shares at an average price of $0.82 on Sep 09. The insider now owns 1,896,820 shares following the transaction. On Sep 08, Chief Executive Officer LONDONER KENNETH L bought 22,766 shares at $0.84 apiece. The transaction was valued at $19,073.

Valuation Metrics

The stock’s beta is 1.38. Besides these, the trailing price-to-sales (P/S) ratio of 336.63, the price-to-book (PB) ratio of 48.67.

Financial Health

In the three months ended March 30, BioSig Technologies Inc.’s quick ratio stood at 0.60, while its current ratio was 0.80, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 79.90% percent. Based on annual data, BSGM earned $0.23 million in gross profit and brought in $0.29 million in revenue.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. BSGM’s revenue fell 0.0% to $0.14 million during the quarter, while net income inched up to $10000.0. While analysts expected BioSig Technologies Inc. to report -$0.1 quarterly earnings, the actual figure was -$0.12 per share. During the quarter, the company generated -$7.3 million in EBITDA. The liabilities of BioSig Technologies Inc. were 3.29 million at the end of its most recent quarter ended March 30, and its total debt was $0.69 million. The value of shareholders’ equity is $70.48 million.

Technical Picture

This quick technical analysis looks at BioSig Technologies Inc.’s (BSGM) price momentum. With a historical volatility rate of 56.22%, the RSI 9-day stood at 72.00% on 24 May.

With respect to its five-day moving average, the current BioSig Technologies Inc. price is up by +2.69% percent or $0.0401. At present, BSGM shares trade +25.42% above its 20-day simple moving average and +264.31% percent above its 100-day simple moving average. However, the stock is currently trading approximately +73.25% above its SMA50 and +147.47% above its SMA200.

Stochastic coefficient K was 65.35% and Stochastic coefficient D was 59.44%, while ATR was 0.1139. Given the Stochastic reading of 73.83% for the 14-day period, the RSI (14) reading has been calculated as 68.53%. As of today, the MACD Oscillator reading stands at 0.0311, while the 14-day reading stands at 0.0715.

Analyst Ratings

BioSig Technologies Inc. (BSGM) has been rated Buy by analysts. According to 0 brokerage firms, BSGM is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate BioSig Technologies Inc. stock as buy, with 2 recommending it as overweight.

With a median target price of $3.63, the current consensus forecast for the stock is $2.00 – $5.25. Based on these forecasts, analysts predict BioSig Technologies Inc. (BSGM) will achieve an average price target of $3.63.


Please enter your comment!
Please enter your name here